VF
AUPH icon

Virtu Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Virtu Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,434
Closed -$226K – 1653
2025
Q3 		$226K Buy
+20,434
New +$223K 0.01% 864
2025
Q2 		– Sell
-14,727
Closed -$118K – 1442
2025
Q1 		$118K Buy
14,727
+4,074
+38% +$33K 0.01% 904
2024
Q4 		$96K Buy
+10,653
New +$86.9K 0.01% 1030
2024
Q3 		– Sell
-54,102
Closed -$309K – 1359
2024
Q2 		$309K Buy
54,102
+38,511
+247% +$203K 0.02% 587
2024
Q1 		$78K Buy
+15,591
New +$106K 0.01% 958
2023
Q3 		– Sell
-15,795
Closed -$153K – 1291
2023
Q2 		$153K Buy
+15,795
New +$164K 0.01% 901
2023
Q1 		– Sell
-30,873
Closed -$133K – 1521
2022
Q4 		$133K Buy
+30,873
New +$179K 0.02% 855
2022
Q3 		– Sell
-20,658
Closed -$208K – 1715
2022
Q2 		$208K Buy
20,658
+805
+4% +$9K 0.02% 749
2022
Q1 		$246K Buy
+19,853
New +$307K 0.02% 676
2021
Q3 		– Sell
-67,123
Closed -$870K – 1492
2021
Q2 		$870K Buy
+67,123
New +$855K 0.08% 247
2019
Q4 		$412K Sell
20,326
-2,462
-11% -$22.7K 0.04% 507
2019
Q3 		$122K Buy
+22,788
New +$138K 0.01% 1049
2019
Q1 		– Sell
-15,458
Closed -$105K – 1402
2018
Q4 		$105K Buy
+15,458
New +$89.1K 0.01% 1120
2018
Q3 		– Sell
-17,511
Closed -$99K – 1530
2018
Q2 		$99K Buy
+17,511
New +$97.7K 0.01% 1648
2017
Q4 		– Sell
-37,009
Closed -$232K – 2352
2017
Q3 		$232K Buy
+37,009
New +$233K 0.01% 1669

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial's AUPH Position: Q4 2025 in Review

Virtu Financial sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2025, closing a stake of 20,434 shares — an estimated $226K sold.

Virtu Financial first reported a position in AUPH in Q3 2017 and held it in 15 quarters. The position peaked at $870K in Q2 2021. 255 funds tracked by Wall St. Rank hold AUPH as of Q4 2025.

  • Virtu Financial reported no remaining Aurinia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 20,434 Aurinia Pharmaceuticals shares in Q4 2025, an estimated $226K.
  • Virtu Financial first reported a position in Aurinia Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • Virtu Financial's Aurinia Pharmaceuticals position peaked at $870K in Q2 2021.
  • 255 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.